N. Jagota

发表

Determination of trace levels of hydrazine in the penultimate intermediate of a novel anti-infective agent.

N. Jagota, A. Chetram, J. B. Nair, 1998, Journal of pharmaceutical and biomedical analysis.

A rationale for determining, testing, and controlling specific impurities in pharmaceuticals that possess potential for genotoxicity.

Lutz Müller, David M. De Antonis, Betsy Fritschel, 2006, Regulatory toxicology and pharmacology : RTP.

Ion chromatography of amylamine and tert.-butylamine in pharmaceuticals.

N. Jagota, A. Chetram, J. B. Nair, 1996, Journal of chromatography. A.

Separation of non-steroidal anti-inflammatory agents using supercritical fluid chromatography.

J. T. Stewart, N. Jagota, 1992, Journal of chromatography.

Supercritical fluid chromatography of selected oestrogens.

J. T. Stewart, N. Jagota, 1992, Journal of pharmaceutical and biomedical analysis.

HPLC Separation of Flavonoids and Flavonoid Glycosides Using a Polystyrene/Divinylbenzene Column

S. Cheatham, N. Jagota, 1992 .

Regulatory and Quality Considerations for Continuous Manufacturing May 20-21, 2014 Continuous Manufacturing Symposium.

Charles Cooney, Frank Montgomery, Jean-Louis Robert, 2015, Journal of pharmaceutical sciences.

Ion chromatography of methanesulfonic acid in pharmaceuticals.

P. Kurtulik, N. Jagota, J. B. Nair, 1995, Journal of pharmaceutical and biomedical analysis.

A supercritical fluid chromatographic method using packed columns for phenylbutazone and oxyphenbutazone in serum, and for phenylbutazone in a dosage form.

J. T. Stewart, N. Jagota, B. R. Simmons, 1995, Journal of pharmaceutical and biomedical analysis.

Regulatory and Quality Considerations for Continuous Manufacturing

Frank Montgomery, William Randolph, Charles L. Cooney, 2017 .

Regulatory and Quality Considerations for Continuous Manufacturing

Yanxi Tan Cain, Tara Gooen Bizjak, M. Nasr, 2017 .